Why patents are a must: The cost of innovation

• In: A4 - Do patents limit access to new medicines? on Tuesday, 2 September 2014, 12:15-13:45
• At: Bangkok (Thailand) (2014)
• Type: Presentation
• By: BERGSTROM, Richard (European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium)
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login